<unk>  (rINN: triplatin tetranitrate) is a new platinum-based cytotoxic drug that is currently undergoing clinical trials throughout the world for the treatment of human cancer. It is a trinuclear platinum coordination complex, with chloride and amine ligands. The drug acts by forming coordinate covalent adducts with cellular DNA, preventing DNA transcription and replication, and through this inducing apoptosis.<unk>  is structurally similar to, but in a different family from, the anticancer drugs cisplatin, carboplatin and oxaliplatin.
BBR3464
R-4066
ALARA
TRPA 
ISFET
MMDA 
ISREC
SeHCAT